| |
| |
|
| Insider
Information: |
Biller Jonathan |
| Relationship: |
EVP and Chief Legal Of... |
| City: |
Summit |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
41,233 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,124,539 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
41,233 |
|
|
| Total
Value |
$8,124,539 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Chief Financial Officer |
2022-02-22 |
22,953 |
2020-04-13 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP and Chief Legal Of... |
2024-02-12 |
18,280 |
2022-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP and Chief Legal Officer |
• – – |
2024-02-12 |
4 |
AS |
$418.77 |
$727,822 |
D/D |
(1,738) |
18,280 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and Chief Legal Officer |
• – – |
2024-02-09 |
4 |
D |
$422.74 |
$671,311 |
D/D |
(1,588) |
20,018 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and Chief Legal Officer |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,743 |
21,606 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and Chief Legal Officer |
• – – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,294 |
16,863 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and Chief Legal Officer |
• – – |
2023-10-02 |
4 |
AS |
$346.76 |
$211,524 |
D/D |
(610) |
10,569 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and Chief Legal Officer |
• – – |
2023-09-29 |
4 |
D |
$350.72 |
$143,094 |
D/D |
(408) |
11,179 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and Chief Legal Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,293 |
11,587 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and Chief Legal Officer |
• – – |
2022-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,294 |
5,294 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2022-02-22 |
4 |
D |
$29.08 |
$78,167 |
D/D |
(2,688) |
22,953 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,523 |
25,641 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2022-02-10 |
4 |
D |
$31.43 |
$42,392 |
D/D |
(1,349) |
17,118 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,667 |
18,467 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2021-12-03 |
4 |
D |
$35.88 |
$65,406 |
D/D |
(1,823) |
14,800 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2021-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,753 |
16,623 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2020-12-03 |
4 |
D |
$45.87 |
$78,300 |
D/D |
(1,707) |
10,040 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2020-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,753 |
11,747 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Legal Officer |
• – – |
2020-04-14 |
4 |
D |
$40.64 |
$102,779 |
D/D |
(2,529) |
5,994 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Legal Officer |
• – – |
2020-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,523 |
8,523 |
0 |
- |
|
| CELG |
Celgene Corp |
EVP AND GENERAL COUNSEL |
• – – |
2019-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
20,387 |
26,652 |
0 |
- |
|
| CELG |
Celgene Corp |
EVP AND GENERAL COUNSEL |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(26,652) |
0 |
0 |
- |
|
| CELG |
Celgene Corp |
EVP AND GENERAL COUNSEL |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(878) |
0 |
0 |
- |
|
| CELG |
Celgene Corp |
EVP AND GENERAL COUNSEL |
• – – |
2019-10-31 |
4 |
D |
$108.03 |
$112,783 |
D/D |
(1,044) |
6,265 |
0 |
- |
|
| CELG |
Celgene Corp |
EVP AND GENERAL COUNSEL |
• – – |
2019-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
7,309 |
0 |
- |
|
| CELG |
Celgene Corp |
EVP AND GENERAL COUNSEL |
• – – |
2019-05-02 |
4 |
D |
$95.21 |
$46,653 |
D/D |
(490) |
4,184 |
0 |
- |
|
| CELG |
Celgene Corp |
EVP AND GENERAL COUNSEL |
• – – |
2019-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,563 |
4,674 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
